Hematuria differential diagnosis: Difference between revisions
No edit summary |
|||
Line 11: | Line 11: | ||
=== Differentiating the diseases that can cause hematuria: === | === Differentiating the diseases that can cause hematuria: === | ||
{| | {| | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan="2" rowspan="5" |Diseases | ! colspan="2" rowspan="5" |Diseases | ||
| colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
! | |||
! | |||
! | |||
! | |||
! | |||
| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
|- | |- | ||
| colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examina | ||
!tion | |||
! | |||
! | |||
! | |||
! | |||
|- | |- | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosi | ||
! colspan="0" rowspan="3" |CT scans method | |||
! colspan="0" rowspan="3" |CT scan | |||
! | |||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
Line 34: | Line 48: | ||
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pitting edema | ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pitting edema | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
|- | |- | ||
Line 41: | Line 53: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Oliguria | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Oliguria | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
|- | |- | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | ||
Line 56: | Line 68: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | '''Biopsy:''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | IgA deposited in a diffuse granular patte | ||
| style="background: #F5F5F5; padding: 5px;" | -rn in the mesangium | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 85: | Line 97: | ||
* Red cell [[casts]] | * Red cell [[casts]] | ||
* Cylindrical [[casts]] | * Cylindrical [[casts]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |'''Biopsy:''' | ||
* | * Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of typ-e IV collagen | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High-frequency sensorineural hearing loss | * High-frequency sensorineural hearing loss | ||
Line 113: | Line 125: | ||
* Urine samples for protein and blood | * Urine samples for protein and blood | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
'''Biopsy''' | |||
* Irregularly thin and attenuated GBM | * Irregularly thin and attenuated GBM | ||
* Splitting of GBM | * Splitting of GBM | ||
* Scarring | * Scarring | ||
| style="background: #F5F5F5; padding: 5px;" | | * Immunoglobulin G and C3 in a diffuse granular pattern | ||
* Starr-y sky pattern | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 149: | Line 159: | ||
* Hepatitis B or C infection | * Hepatitis B or C infection | ||
* Antineutrophil cytoplasmic antibody titers, serum protein electrophoresis | * Antineutrophil cytoplasmic antibody titers, serum protein electrophoresis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |'''Biopsy''' | ||
* | * Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | ||
| style="background: #F5F5F5; padding: 5px;" | | * Coarsely granular deposits -of IgM and C3 | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 182: | Line 193: | ||
* Eleated LDH and CPK | * Eleated LDH and CPK | ||
* Proteinuria | * Proteinuria | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | Biopsy: | ||
| style="background: #F5F5F5; padding: 5px;" | | * Diffuse, proliferative, necrotizing glomerulonephritis with cresc-ent formation | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | 80% of patients have ANCA-positive microscopic polyangiitis | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |Biospy | | style="background: #F5F5F5; padding: 5px;" |Biospy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | ||
Line 208: | Line 220: | ||
* Cellular casts | * Cellular casts | ||
* Low iron | * Low iron | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | Biopsy, | ||
| style="background: #F5F5F5; padding: 5px;" | | * Different pathologies, [[Lupus nephritis|CLICK HERE]] for more- information. | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 229: | Line 242: | ||
* Hematuria | * Hematuria | ||
* Proteinuria | * Proteinuria | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |Non-specific+/- nephrotic picture | | style="background: #F5F5F5; padding: 5px;" |Non-specific+/- nephrotic picture | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
Line 249: | Line 261: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 271: | Line 282: | ||
* [[Eosinophiluria]] | * [[Eosinophiluria]] | ||
* [[Isosthenuria]] | * [[Isosthenuria]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Biopsy: | ||
* [[Edema]] and infiltration by mononuclear cells, (principally lymphocytes) | |||
* [[Eosinophils]] are present, often in large numbers. | |||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |Renal biopsy | | style="background: #F5F5F5; padding: 5px;" |Renal biopsy | ||
Line 298: | Line 309: | ||
* [[Hyperuricemia]] | * [[Hyperuricemia]] | ||
* [[Hyperuricosuria]] | * [[Hyperuricosuria]] | ||
| style="background: #F5F5F5; padding: 5px;" |Hydronephrosis +/- | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * Hydronephrosis +/- in sonography | ||
* Abdominal CT scan without contrast | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
Line 324: | Line 337: | ||
* Hyperkalemia | * Hyperkalemia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Ultrasound: Hydronephrosis +/- | |||
Kidney | * Biopsy: Kidney scar | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 349: | Line 363: | ||
* Anemia | * Anemia | ||
* Hematuria | * Hematuria | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Both [[CT]] and [[MRI]] may be used to detect [[neoplastic]] masses that may define renal cell carcinoma or metastasis of the primary cancer. [[CT]] scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with [[Renal cell carcinoma|renal cell carcinom]]<nowiki/>a. | |||
* The histological pattern of renal cell [[carcinoma]] depends whether it is [[Papillary|papillary,]] [[chromophobe]] or [[collecting duct]] renal cell carcinoma. | |||
| style="background: #F5F5F5; padding: 5px;" |– | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |– | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 372: | Line 387: | ||
* [[Hematuria]] | * [[Hematuria]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | *Ultrasound is the best initial diagnostic study used in cases suspected with [[Wilms tumor]].<ref name="pmid61529362">{{cite journal |vauthors=Hartman DS, Sanders RC |title=Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation |journal=J Ultrasound Med |volume=1 |issue=3 |pages=117–22 |date=April 1982 |pmid=6152936 |doi= |url=}}</ref> | ||
*[[Doppler ultrasonography]] can help to detect invasion of [[renal vein]] and [[Inferior vena cava|IVC]] by the tumor.<ref name="pmid30036602">{{cite journal |vauthors=De Campo JF |title=Ultrasound of Wilms' tumor |journal=Pediatr Radiol |volume=16 |issue=1 |pages=21–4 |date=1986 |pmid=3003660 |doi= |url=}}</ref> | *[[Doppler ultrasonography]] can help to detect invasion of [[renal vein]] and [[Inferior vena cava|IVC]] by the tumor.<ref name="pmid30036602">{{cite journal |vauthors=De Campo JF |title=Ultrasound of Wilms' tumor |journal=Pediatr Radiol |volume=16 |issue=1 |pages=21–4 |date=1986 |pmid=3003660 |doi= |url=}}</ref> | ||
*Findings on [[CT scan]]:<ref name="pmid4080660">{{cite journal |vauthors=Cahan LD |title=Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease |journal=Pediatr Neurosci |volume=12 |issue=1 |pages=58–62 |date=1985 |pmid=4080660 |doi= |url=}}</ref> | |||
*Findings on [[CT scan]] | |||
**Heterogeneous soft-tissue density masses | **Heterogeneous soft-tissue density masses | ||
**Abdominal lymph nodes and contralateral involvement | **Abdominal lymph nodes and contralateral involvement | ||
'''Biopsy:''' | |||
* Primitive tubules and [[Glomerulus|glomeruli]] are often seen comprised of [[Cancer|neoplastic]] cells. | |||
* Spindled cell [[stroma]] surrounding abortive tubules and [[Glomerulus|glomeruli]] is characteristic. | |||
*The stroma may include: | |||
**Striated [[muscle]] [[cartilage]] | |||
**[[bone]] | |||
**[[Adipose tissue|Fat tissue]] | |||
**[[Fibrous connective tissue|Fibrous tissue.]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Wilms tumor has a triphasic appearance. | *Wilms tumor has a triphasic appearance. | ||
Line 392: | Line 407: | ||
**[[Blastema|Blastemal]] | **[[Blastema|Blastemal]] | ||
*All the 3 types are not required for the diagnosis of Wilms tumor. | *All the 3 types are not required for the diagnosis of Wilms tumor. | ||
* | * | ||
*Beckwith and Palmer reported in NWTS the different histopathologic types of Wilms tumor to categorize them based on prognosis.<ref name="pmid1978">{{cite journal |vauthors=Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN |title=Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases |journal=Adv Vet Sci Comp Med |volume=19 |issue=23 |pages=1–21 |date=November 1975 |pmid=1978 |doi= |url=}}</ref> | *Beckwith and Palmer reported in NWTS the different histopathologic types of Wilms tumor to categorize them based on prognosis.<ref name="pmid1978">{{cite journal |vauthors=Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN |title=Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases |journal=Adv Vet Sci Comp Med |volume=19 |issue=23 |pages=1–21 |date=November 1975 |pmid=1978 |doi= |url=}}</ref> | ||
* | ** | ||
* | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 419: | Line 429: | ||
* [[Anemia]] | * [[Anemia]] | ||
* [[Hematuria]] | * [[Hematuria]] | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 436: | Line 445: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Anemia]] | * [[Anemia]] | ||
* [[Hematuria]] | * [[Hematuria]] | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound, CT scan, Biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 460: | Line 468: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 489: | Line 496: | ||
* [[Hematuria]] ([[microscopic]] or [[macroscopic]]) | * [[Hematuria]] ([[microscopic]] or [[macroscopic]]) | ||
* [[Proteinuria]] usually less than 1 g/day | * [[Proteinuria]] usually less than 1 g/day | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Ultrasound: | ||
* Unilateral or bilateral [[cysts]] | * Unilateral or bilateral [[cysts]] | ||
CT: | |||
* Hyperdense appearance, | * Hyperdense appearance, | ||
* Septations | * Septations | ||
* Calcifications | * Calcifications | ||
[[Genetic]] testing demonstrates: | [[Genetic]] testing demonstrates: | ||
* Frame insertions/deletions | * Frame insertions/deletions | ||
* Non-canonical [[splice]] site alterations | * Non-canonical [[splice]] site alterations | ||
* Combined [[missense]] changes | * Combined [[missense]] changes | ||
Biopsy: | |||
* Interstitial fibrosis | * Interstitial fibrosis | ||
* Tubular atrophy | * Tubular atrophy | ||
* Thickening and lamellation of tubular basement membranes | * Thickening and lamellation of tubular basement membranes | ||
* Microcysts | * Microcysts | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Ultrasound | | style="background: #F5F5F5; padding: 5px;" |Ultrasound | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan=" | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular anomaly|Vascular diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal vein thrombosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal vein thrombosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 530: | Line 539: | ||
* Serum complement levels | * Serum complement levels | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Ultrasound, | ||
* Venography | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
* | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |'''Renal venography:''' Gold standard | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 576: | Line 553: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 588: | Line 565: | ||
* Microscopic hematuria | * Microscopic hematuria | ||
* RBC casts | * RBC casts | ||
| style="background: #F5F5F5; padding: 5px;" | CT chest: | |||
| style="background: #F5F5F5; padding: 5px;" |CT chest | |||
* Multiple [[Pulmonary nodule|lung nodules]] | * Multiple [[Pulmonary nodule|lung nodules]] | ||
* [[Consolidation (medicine)|Consolidation]] | * [[Consolidation (medicine)|Consolidation]] | ||
* [[Ground glass opacification on CT|Ground-glass opacities.]] | * [[Ground glass opacification on CT|Ground-glass opacities.]] | ||
| style="background: #F5F5F5; padding: 5px;" | | Biopsy: | ||
* Subendothelial [[edema]] | |||
* Microthrombosis, and | |||
* [[Degranulation]] of [[neutrophils]]. | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Subendothelial [[edema]] | * Subendothelial [[edema]] | ||
Line 604: | Line 585: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Henoch-Schönlein purpura]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Henoch-Schönlein purpura]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Abdominal pain | |||
* Rash | |||
* Hematuria | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Proteniuria | |||
* Microscopic hematuria | |||
* RBC casts | |||
| style="background: #F5F5F5; padding: 5px;" |Biopsy: | |||
IgA deposited in a diffuse granular pattern in the mesangium | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Renal biopsy, and clinical syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 634: | Line 622: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 666: | Line 653: | ||
* High PSA values | * High PSA values | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Urine cytology to screen for bladder cancer | ||
* Biopsy to rule out cancer | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 682: | Line 667: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 697: | Line 681: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Interstitial cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 716: | Line 699: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Radiogenic|Radiogenic cystitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 736: | Line 718: | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemophilia|Coagulopathy (hemophilia)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 755: | Line 736: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sickle cell anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 774: | Line 754: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Abdominal aortic aneurysm]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 793: | Line 772: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomas]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 812: | Line 790: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple myeloma]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 842: | Line 819: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis method | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 866: | Line 842: | ||
* Positive [[leukocyte esterase]] test and [[nitrite test]]. | * Positive [[leukocyte esterase]] test and [[nitrite test]]. | ||
* Blood/urine cultures | * Blood/urine cultures | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |CT and ultrasound: | ||
* Enlarged kidneys | * Enlarged kidneys | ||
* Round swollen [[Kidney|kidneys]] | * Round swollen [[Kidney|kidneys]] | ||
* Hypodense appearance | * Hypodense appearance | ||
* [[Abscess|Abscesses]] may not be present | * [[Abscess|Abscesses]] may not be present | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 900: | Line 870: | ||
* Positive urine/blood cultures | * Positive urine/blood cultures | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Ultrasound: | |||
* Presence of a gas in the bladder wall. | * Presence of a gas in the bladder wall. | ||
* Also help to detect the presence of a [[tumor]] or a [[Stone massage|stone]]. | * Also help to detect the presence of a [[tumor]] or a [[Stone massage|stone]]. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | |||
* | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Urine culture | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 929: | Line 897: | ||
* Elevated [[C-reactive protein]] | * Elevated [[C-reactive protein]] | ||
* Transiently elevated [[PSA]] (prostate specific antigen) levels | * Transiently elevated [[PSA]] (prostate specific antigen) levels | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Ultrasound: | ||
* Focal hypoechoic region located in the peripheral part of the [[prostate]] | * Focal hypoechoic region located in the peripheral part of the [[prostate]] | ||
CT scan: | |||
* Edema of the [[prostate gland]] with diffuse enlargement,. | * Edema of the [[prostate gland]] with diffuse enlargement,. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 958: | Line 923: | ||
* Positive leukocyte esterase test. | * Positive leukocyte esterase test. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
CT scan: | |||
* Diffuse, circumferential urothelial wall thickening and contrast-enhancement | * Diffuse, circumferential urothelial wall thickening and contrast-enhancement | ||
* Periureteric or perinephric fat stranding. | * Periureteric or perinephric fat stranding. | ||
Line 977: | Line 941: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 989: | Line 952: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 16:52, 1 February 2019
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Omer Kamal, M.D.[1], Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.
Hematuria differential diagnosis
Differentiating the diseases that can cause hematuria:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examina | tion | |||||||||||||||||
Lab Findings | Diagnosi | CT scans method | CT scan | Histopathology | |||||||||||||||
Low back pain | Fever | Nausea/
Vomiting |
Urinary symptoms | Hypertension | Pitting edema | Other | Other | ||||||||||||
Dysuria | Frequency | Oliguria | |||||||||||||||||
Glomerular diseases | IgA nephropathy (Berger nephropathy) | + | - | - | - | + | + | + | - | - | Biopsy:
IgA deposited in a diffuse granular patte |
-rn in the mesangium |
|
|
|
Biopsy | - | ||
Hereditary nephritis (Alport syndrome) | - | - | - | - | - | - | + | - |
|
Biopsy:
|
|
- |
|
|
- | ||||
Poststreptococcal glomerulonephritis | +/- | + | - | - | + | + | + | + |
|
|
Biopsy
|
- |
|
Biopsy | - | ||||
Focal segmental glomerular sclerosis | - | - | - | - | - | - | + | + |
|
|
Biopsy
|
- |
|
|
Biopsy | - | |||
Rapidly progressive glomerulonephritis | + | + | + | - | - | - | + | - |
|
|
Biopsy:
|
80% of patients have ANCA-positive microscopic polyangiitis | - | Biospy | |||||
Lupus nephritis | - | + | - | - | - | - | + | + |
|
|
Biopsy,
|
- | - | - | Biopsy | - | |||
Fabry disease | - | - | - | - | - | - | + | + | - |
|
Biopsy | - | Non-specific+/- nephrotic picture | - | Biopsy | - | |||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Other | Gold standard | Additional findings | |||||
Tubulointerstitial diseases | + | + | + | – | – | – | – | – | Rash | Biopsy:
|
– |
|
– | Renal biopsy | |||||
Nephrolithiasis | + | ± | + | ± | ± | ± | – | – |
|
|
– | – | – | Abdominal Ct scan without contrast | – | ||||
Reflux nephropathy (hydronephrosis) | + | + | - | - | - | - | - | + |
|
– | – | ||||||||
Malignancy | Renal cell carcinoma (RCC) | - | - | - | - | - | - | ± | ± |
|
|
|
– | – | |||||
Nephroblastoma (Wilms tumor) | - | - | - | - | - | - | - | - |
|
Biopsy:
|
|
Biopsy | |||||||
Bladder cancer | - | - | - | - | ± | ± | - | - | Suprapubic pain | Ultrasound, CT scan, Biopsy | - | Biopsy | |||||||
Prostate cancer | ± | - | - | - | ± | ± | - | - | - | Ultrasound, CT scan, Biopsy | Biopsy | ||||||||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Other | Gold standard | Additional findings | |||||
Familial diseases | Polycystic kidney disease | + | - | - | - | - | - | + | + |
|
Ultrasound:
CT:
Genetic testing demonstrates: Biopsy:
|
Ultrasound | |||||||
Vascular diseases | Renal vein thrombosis | + | + | + | - | - | - | - | - |
|
|
|
- | Renal venography: Gold standard | |||||
Wegner's granulomatosis polyangiitis | - | - | - | - | - | +/- | + | + |
|
|
CT chest:
Biopsy:
|
- |
|
- | Biopsy | ||||
Henoch-Schönlein purpura | - | - | - | - | - | +/- | +/- | + |
|
|
Biopsy:
IgA deposited in a diffuse granular pattern in the mesangium |
Renal biopsy, and clinical syndrome | |||||||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Other | Gold standard | Additional findings | |||||
Lower urinary tract diseases | Benign prostatic hyperplasia | +/- | - | - | + | + | - | - | - |
|
|
|
|
Biopsy | |||||
Urolithiasis | + | +/- | + | + | |||||||||||||||
Interstitial cystitis | |||||||||||||||||||
Radiogenic cystitis | |||||||||||||||||||
Systemic diseases | Coagulopathy (hemophilia) | ||||||||||||||||||
Sickle cell anemia | |||||||||||||||||||
Abdominal aortic aneurysm | |||||||||||||||||||
Lymphomas | |||||||||||||||||||
Multiple myeloma | |||||||||||||||||||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Other | Gold standard | Additional findings | |||||
Infectious diseases | Pyelonephritis | + | + | + | + | + | + | - | - |
|
CT and ultrasound: | - | - | ||||||
Cystitis | - | - | - | + | + | + | - | - |
|
|
|
|
Urine culture | ||||||
Prostatitis | - | + | - | + | + | + | - | - |
|
|
Ultrasound:
CT scan:
|
- | |||||||
Urethritis | -/- | + | - | + | + | + | - | - |
|
|
CT scan:
|
- | |||||||
Epididymitis | -/+ | + | + | - | - | - | - | - | |||||||||||
Urogenital trauma | Inserted bladder or ureteral catheters |
References
- ↑ Hartman DS, Sanders RC (April 1982). "Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation". J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). "Ultrasound of Wilms' tumor". Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). "Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease". Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.
- ↑ Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN (November 1975). "Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases". Adv Vet Sci Comp Med. 19 (23): 1–21. PMID 1978.